NVAX · Novavax Inc
$8.05
-0.09 (-1.11%)
At close · Aug 14
Market Cap
$1.33B
Shares
164.95M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| John C. Jacobs | President and CEO | $8,856,015 |
| Elaine O'Hara | EVP, Chief Strategy Officer | $3,688,276 |
| James Kelly | EVP, Chief Financial Officer and Treasurer | $2,986,228 |
| Mark J. Casey | EVP, Chief Legal Officer and Corporate Secretary | $2,810,453 |
| Ruxandra Draghia-Akli | M.D., Ph.D. Former EVP, Head of Research & Development | $2,303,380 |
| John Trizzino | COO | $1,709,950 |
| John J. Trizzino | Former President and Chief Operating Officer | $1,709,950 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| John C. Jacobs | President and CEO | $5,087,461 |
| James Kelly | EVP, Chief Financial Officer and Treasurer | $1,829,489 |
| Elaine O'Hara | EVP, Chief Strategy Officer | $1,638,116 |
| John Trizzino | COO | $1,633,417 |
| John J. Trizzino | President and Chief Operating Officer | $1,633,417 |
| Filip Dubovsky | Former President, Research & Development | $1,554,368 |
| Mark J. Casey | EVP, Chief Legal Officer and Corporate Secretary | $1,062,334 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| John C. Jacobs | President and CEO | $7,269,509 |
| Stanley C. Erck | Former President and CEO | $3,827,483 |
| Filip Dubovsky | Former President, Research & Development | $1,934,392 |
| John J. Trizzino | President and Chief Operating Officer | $1,877,883 |
| John Trizzino | COO | $1,877,883 |
| Mark J. Casey | EVP, Chief Legal Officer and Corporate Secretary | $1,534,587 |
| James Kelly | EVP, Chief Financial Officer and Treasurer | $1,503,833 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Stanley C. Erck | Former President and CEO | $8,401,283 |
| Gregory Glenn | Former President, Research and Development | $4,093,686 |
| James Kelly | EVP, Chief Financial Officer and Treasurer | $3,181,336 |
| John A. Herrmann III | EVP, Chief Legal Officer and Corporate Secretary | $3,095,314 |
| John J. Trizzino | President and Chief Operating Officer | $3,078,230 |
| John Trizzino | COO | $3,078,230 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| James Kelly | EVP, Chief Financial Officer and Treasurer | $4,925,939 |
| Stanley C. Erck | Former President and CEO | $1,118,030 |
| John J. Trizzino | President and Chief Operating Officer | $1,064,179 |
| John Trizzino | COO | $1,064,179 |
| Gregory Glenn | Former President, Research and Development | $813,444 |
| John A. Herrmann III | EVP, Chief Legal Officer and Corporate Secretary | $657,802 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Stanley C. Erck | Former President and CEO | $48,086,018 |
| Gregory Glenn | Former President, Research and Development | $24,923,376 |
| John Trizzino | — | $21,327,954 |
| John J. Trizzino | EVP, Chief Commercial Officer and Chief Business Officer | $21,327,954 |
| John A. Herrmann III | EVP, Chief Legal Officer and Corporate Secretary | $20,606,814 |
| Gregory Covino | Former EVP, Chief Financial Officer and Treasurer | $1,417,774 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Stanley C. Erck | President and CEO | $2,438,562 |
| Gregory Glenn | President, Research and Development | $1,875,198 |
| John J. Trizzino | EVP, Chief Commercial Officer, Chief Business Officer and Interim Chief Financial Officer | $1,465,602 |
| John Trizzino | CFO | $1,465,602 |
| John A. Herrmann III | EVP, Chief Legal Officer and Corporate Secretary | $1,353,416 |
| Gregory Covino | Former EVP, Chief Financial Officer and Treasurer | — |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Stanley C. Erck | President and CEO | $4,158,398 |
| Gregory Glenn | President, Research and Development | $1,681,456 |
| John Trizzino | CFO | $1,329,776 |
| John J. Trizzino | EVP, Chief Commercial Officer, Chief Business Officer and Interim Chief Financial Officer | $1,329,776 |
| John A. Herrmann III | EVP, Chief Legal Officer and Corporate Secretary | $1,137,576 |
| Gregory Covino | Former EVP, Chief Financial Officer and Treasurer | — |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Stanley C. Erck | President and CEO | $2,771,685 |
| Gregory Glenn | President, Research and Development | $1,221,250 |
| John J. Trizzino | SVP, Chief Business Officer and CFO and Treasurer | $947,747 |
| John Trizzino | CFO | $947,747 |
| John A. Herrmann III | SVP, General Counsel and Corporate Secretary | $913,317 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| John Trizzino | Chief Operating Officer | Terminated | 2025-05-27 |
| Charles W. Newton | Class III director | Appointed | 2025-04-29 |
| John W. Shiver | Class III director | Appointed | 2025-03-11 |
| James F. Young | Board of Directors | Resigned | 2025-03-11 |
| Margaret G. McGlynn | Class II nominee for director | Appointed | 2024-06-14 |
| David Mott | Class II nominee for director | Appointed | 2024-06-14 |
| Richard H. Douglas, Ph.D. | Class II nominee for director | Appointed | 2024-06-14 |
| Filip Dubovsky | President, Research and Development | Retired | 2024-05-23 |
| John A. Herrmann III | Chief Legal Officer and Corporate Secretary | Retired | 2023-11-17 |
| John J. Trizzino | President and Chief Operating Officer | Appointed | 2023-11-17 |
| Gregg H. Alton, J.D. | Class I nominee for director | Appointed | 2023-07-11 |
| Richard J. Rodgers | Class I nominee for director | Appointed | 2023-07-11 |
| John C. Jacobs | Class I nominee for director | Appointed | 2023-07-11 |
| Dr. Gregory M. Glenn, M.D. | President, Research and Development | Retired | 2023-03-22 |
| Dr. Gregory M. Glenn, M.D. | President, Research and Development | Retired | 2023-03-02 |
| Stanley C. Erck | member of the Board | Retired | 2023-01-09 |
| John C. Jacobs | member of the Board | Appointed | 2023-01-09 |
| Stanley C. Erck | President and Chief Executive Officer | Retired | 2023-01-09 |
| John C. Jacobs | President and Chief Executive Officer | Appointed | 2023-01-09 |
| Richard J. Rodgers | Class I director | Appointed | 2022-11-01 |
| James F. Young | Class III nominee for director | Appointed | 2022-06-21 |
| Rachel K. King | Class III nominee for director | Appointed | 2022-06-21 |
| Rajiv I. Modi, Ph.D. | Board | Resigned | 2022-03-07 |
Key facts
CIK
1000694
CUSIP
670002401
13F (30d)
276 filings
251 filers
Visit website
Investor relations